KATHMANDU: The Department of Drug Administration (DoA) has given approval to the use of covishield vaccine against COVID-19 in Nepal.
The covishield vaccine is developed by Serum Institute of India.
“Conditional permission has been granted for emergency use authorization of covishield vaccine against COVID-19 as per the decision of the department,” reads a press statement issued by DoA) today.